Substitution Treatment Doesn’t Reduce Mortality in Subclinical Hypothyroidism Patients
A new study adds important data to a longstanding debate: Should subclinical hypothyroidism be treated with levothyroxine? Determining the answer has heightened urgency because the condition is associated with increased risks of hypertension and hypercholesterolemia, which can lead to cardiovascular issues.
Find out
how researchers determined that thyroid substitution therapy had no effect on overall mortality rates in patients with subclinical hypothyroidism.